Focus Stocks
Branham Law Group Investigates Pfizer for Qualitest Packaging Error Recall
Published on Thursday, 09 February 2012 14:22 Written by TradersHuddle Staff
DALLAS-( Business Wire )-Branham Law Group, LLP, a Dallas, Texas law firm, is investigating Pfizer (NYSE: PFE) for its recall of 14 lots of Lo/Ovral-28 tablet packs and 14 lots of generic Norgestrel and Ethinyl Estradiol tablets. Pfizer manufactured both drugs and they were marketed in the United States by Akrimax Rx Products under the Akrimax Pharmaceuticals brand. The expiration dates on these contraceptives range from July 31, 2013 through March 31, 2014.
“We are very concerned about these recalls and the potential effects of Pfizer’s error,” said Trey Branham, Managing Partner of the Branham Law Group. If you currently take Lo/Ovral-28 tablet packs, Norgestrel or Ethinyl Estradiol, and have suffered health complications or pregnancy as a result of the mis-packaged medication or have a question about the recall and your rights, please contact Branham Law Group, LLP immediately. Branham Law Group has extensive experience in pharmaceutical litigation. Anyone taking these drugs - or anyone with knowledge about this recall - should contact lawyer Trey Branham at This e-mail address is being protected from spambots. You need JavaScript enabled to view it. or 1-855-722-5910.
The Branham Law Group, LLP has extensive experience in pharmaceutical litigation and catastrophic injury. The Branham Law Group also advises whistleblowers on appropriate courses of actions.
Related Articles
- FDA Advisory Committee Finds Data Support Effectiveness of Tafamidis Meglumine, Pfizer’s Novel Investigational Treatment for Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP)
- Pfizer Names Olivier Brandicourt as President and General Manager, Emerging Markets and Established Products Business Units
- Pfizer Teams With EatingWell To Launch Free Mobile App
- Pfizer Invites Public to View and Listen to Webcast of June 3 Pfizer Analyst and Investor Meeting at ASCO
- Pfizer Exploratory Study Measures Effects Of Lyrica (pregabalin) On Brain Activity In Fibromyalgia Patients
- Pfizer Is Near its 50 Day Moving Average
- High Above Average Volume on Pfizer
- Pfizer Provides Topline Results From Phase 3 Study Of Torisel® As Second-Line Treatment In Advanced Renal Cell Carcinoma (RCC)
- Pfizer High Volume Day?
- Pfizer High Volume Day?
Related Partner Headlines
- Pfizer Inc (PFE): Today's Featured Drugs Loser - TheStreet.com
- Pfizer Inc (PFE): Today's Featured Drugs Loser - TheStreet.com
- UPDATE: Pfizer Says Didn't Meet Primary Endpoint - Benzinga
- Dow Today: Pfizer (PFE) Higher - TheStreet.com
- UPDATE: Pfizer Announces FDA Arthritis Advisory Committee Recommends Approval of Tofacitinib - Benzinga
- Pfizer Stock To Go Ex-dividend Tomorrow (PFE) - TheStreet.com
- UPDATE: Pfizer Announces New Long-Term Relapse Prevention Data For PRISTIQ® (desvenlafaxine) 50 mg/day For The Treatment Of Major Depressive Disorder In Adults - Benzinga
- Pfizer Inc (PFE): Today's Featured Drugs Loser - TheStreet.com
- Future of Pfizer: It's the R&D, Stupid! - TheStreet.com
- Dow Today: Travelers Companies (TRV) Leads The Day Higher, Pfizer (PFE) Lags - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Top 4 Small-Cap Stocks In The Heavy Construction Industry With The Lowest PEG Ratio - Benzinga -
Earnings Scheduled For May 25 - Benzinga -
Cramer's 'Mad Money' Recap: Big Government Not Protecting the Little Guys - TheStreet.com -
The Global Retrenchment Accelerates - TheStreet.com -
Bain Capital Sent 0,000-Plus to Obama and Dems in 2008 - TheStreet.com -
Market Preview: Low-Grade Uncertainty - TheStreet.com -
The EPA's Dangerous Game - TheStreet.com -
Sticking with the Preferred Plan - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,529.75 Trade time:4:05PM EDT Value change:▲33.60 (0.27%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,320.68 Trade time:4:32PM EDT Value change:▲1.82 (0.14%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,839.38 Trade time:5:16PM EDT Value change:▼10.74 (-0.38%)In The Wires
-
Syngenta settles atrazine litigation in the USA -
Atrazine Litigation Settled -
eMazzanti Attains Xerox Gold Partner Status -
USFS, BLM Hire Youth for Public Lands Conservation Jobs -
SCVBank Elects Scott K. Rushing as New Chairman -
Heritage Oaks Bancorp to Pay Trust Preferred Interest and Accumulated TARP Dividends -
Law Office of Brodsky & Smith, LLC Announces Investigation of Ariba, Inc. -
Following Its Record 73% Jump FY 2011 Revenue, Privately-Held Milton Security Group Reports Repeat Double-Digit Sales Growth for First Quarter 2012









